Pharos iBio Co., Ltd. (KOSDAQ:388870)

Pharos iBio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5,435	25,533	6,360	15,588	3,812	18,812
Short-Term Investments	10,607	480.86	9,308	9,899	11,267	5,000
Cash & Short-Term Investments	22,303	26,014	15,668	25,487	15,079	23,812
Cash Growth	126.66%	66.03%	-38.53%	69.02%	-36.68%	60.81%
Accounts Receivable	-0	-0	0	0	0	-0
Other Receivables	78.69	34.92	142.02	176.56	195.54	48.02
Receivables	78.69	34.91	142.02	176.56	195.54	48.01
Prepaid Expenses	121.02	88.61	72.26	160.37	167.89	234.56
Other Current Assets	639.78	261.07	371.92	346.75	272.46	327.31
Total Current Assets	23,142	26,398	16,254	26,170	15,715	24,422
Property, Plant & Equipment	2,541	2,382	2,817	3,218	2,541	2,700
Long-Term Investments	-0	-0	0	0.13	0	-0
Other Intangible Assets	368.87	373.46	419.08	148.95	203.04	264.56
Other Long-Term Assets	196.8	714.69	137.78	153.17	262.56	99.59
Total Assets	26,249	29,868	19,628	29,690	18,721	27,486

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	87.18	95.7	217.38	86.3	131.83	51.55
Current Portion of Long-Term Debt	-	-	-	-	106.25	125
Current Portion of Leases	183.74	149.4	82.11	177.25	154.31	151.2
Other Current Liabilities	545.84	1,147	673.72	949.8	558.56	42,373
Total Current Liabilities	816.76	1,392	973.21	1,213	950.95	42,700
Long-Term Debt	8,590	7,731	-	-	-	106.25
Long-Term Leases	91.38	64.27	41.61	127.7	105.12	209.17
Pension & Post-Retirement Benefits	-	-	-	-	-	259.36
Other Long-Term Liabilities	7,034	6,755	0	-0	0	6.87
Total Liabilities	16,532	15,943	1,015	1,341	1,056	43,282

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	6,473	6,473	6,473	6,459	5,738	2,902
Additional Paid-In Capital	102,155	102,155	102,155	101,927	83,576	1,307
Retained Earnings	-107,635	-103,088	-92,332	-81,771	-72,913	-55,997
Comprehensive Income & Other	8,724	8,386	2,317	1,734	1,264	604.87
Total Common Equity	9,717	13,926	18,614	28,349	17,665	-51,184
Shareholders' Equity	9,717	13,926	18,614	28,349	17,665	-15,796
Total Liabilities & Equity	26,249	29,868	19,628	29,690	18,721	27,486

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	8,865	7,945	123.72	304.95	365.68	591.61
Net Cash (Debt)	13,437	18,069	15,544	25,182	14,714	23,221
Net Cash Growth	40.65%	16.24%	-38.27%	71.15%	-36.64%	63.31%
Net Cash Per Share	1037.71	1395.73	1202.59	2080.94	1656.70	4001.05
Filing Date Shares Outstanding	12.97	12.95	12.95	12.92	11.48	5.8
Total Common Shares Outstanding	12.97	12.95	12.95	12.92	11.48	5.8
Working Capital	22,325	25,006	15,281	24,957	14,764	-18,278
Book Value Per Share	749.15	1075.68	1437.79	2194.39	1539.19	-8819.20
Tangible Book Value	9,348	13,552	18,194	28,200	17,462	-51,448
Tangible Book Value Per Share	720.71	1046.83	1405.42	2182.86	1521.50	-8864.79
Land	367	367	367	367	367	367
Buildings	782.08	782.08	782.08	782.08	782.08	782.08
Machinery	2,394	2,310	2,373	1,980	1,445	1,239

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error